Published in Neurology on March 01, 1997
Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet (2016) 10.08
Campylobacter species and Guillain-Barré syndrome. Clin Microbiol Rev (1998) 4.39
Campylobacter upsaliensis: waiting in the wings. Clin Microbiol Rev (1998) 1.63
Recovery patterns and long term prognosis for axonal Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry (2005) 1.52
Guillain Barré syndrome. Mol Pathol (2001) 1.17
Guillain-Barré syndrome and variants. Neurol Clin (2013) 1.06
Guillain-Barré syndrome- and Miller Fisher syndrome-associated Campylobacter jejuni lipopolysaccharides induce anti-GM1 and anti-GQ1b Antibodies in rabbits. Infect Immun (2001) 1.03
Pathophysiological actions of neuropathy-related anti-ganglioside antibodies at the neuromuscular junction. J Physiol (2009) 1.01
The neuropathic potential of anti-GM1 autoantibodies is regulated by the local glycolipid environment in mice. J Clin Invest (2009) 1.00
Patterns of recovery in the Guillain-Barre syndromes. Neurology (1997) 0.99
Comparative characterization of the virulence gene clusters (lipooligosaccharide [LOS] and capsular polysaccharide [CPS]) for Campylobacter coli, Campylobacter jejuni subsp. jejuni and related Campylobacter species. Infect Genet Evol (2012) 0.94
Anti-ganglioside antibodies alter presynaptic release and calcium influx. Neurobiol Dis (2007) 0.89
Association of Campylobacter upsaliensis with persistent bloody diarrhea. J Clin Microbiol (2012) 0.87
Anti-ganglioside antibody internalization attenuates motor nerve terminal injury in a mouse model of acute motor axonal neuropathy. J Clin Invest (2012) 0.87
The pre-synaptic motor nerve terminal as a site for antibody-mediated neurotoxicity in autoimmune neuropathies and synaptopathies. J Anat (2013) 0.84
Anti-Ganglioside Antibodies Induce Nodal and Axonal Injury via Fcγ Receptor-Mediated Inflammation. J Neurosci (2015) 0.82
First case report of fatal sepsis due to Campylobacter upsaliensis. J Clin Microbiol (2014) 0.80
Anti-GM2 ganglioside antibodies are a biomarker for acute canine polyradiculoneuritis. J Peripher Nerv Syst (2013) 0.75
Campylobacter upsaliensis isolated from dogs produces high titer of cytolethal distending toxin. J Vet Med Sci (2017) 0.75
Updated research nosology for HIV-associated neurocognitive disorders. Neurology (2007) 16.18
HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology (2010) 12.32
Adhesive force of a single gecko foot-hair. Nature (2000) 10.56
Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol (1990) 8.54
Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology (2007) 8.08
Evidence-based guideline update: Plasmapheresis in neurologic disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology (2011) 7.09
Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates. Emerg Infect Dis (2001) 5.41
Occupational exposure to inorganic mercury vapour and reproductive outcomes. Occup Med (Lond) (1998) 5.33
Research methodology in occupational medicine. Occup Med (Lond) (1998) 4.88
Immune reconstitution inflammatory syndrome in natalizumab-associated PML. Neurology (2011) 4.63
Practice guidelines for the management of infectious diarrhea. Clin Infect Dis (2001) 4.49
Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann Neurol (1995) 3.78
Spectrum bias in the evaluation of diagnostic tests: lessons from the rapid dipstick test for urinary tract infection. Ann Intern Med (1992) 3.64
The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology (2003) 3.60
HIV-associated neurologic disease incidence changes:: Multicenter AIDS Cohort Study, 1990-1998. Neurology (2001) 3.55
Epidermal nerve fiber density: normative reference range and diagnostic efficiency. Arch Neurol (1998) 3.39
Sequence-based identification of Mycobacterium species using the MicroSeq 500 16S rDNA bacterial identification system. J Clin Microbiol (2000) 3.26
Quantitative sensory testing: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology (2003) 3.23
HIV Dementia Scale: a rapid screening test. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 3.17
EFNS guidelines on the use of skin biopsy in the diagnosis of peripheral neuropathy. Eur J Neurol (2005) 3.17
Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Saharan Africa. Neurology (2007) 3.14
Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Proc Natl Acad Sci U S A (1998) 2.89
Clinical and electrophysiological aspects of acute paralytic disease of children and young adults in northern China. Lancet (1991) 2.87
Practice parameter: immunotherapy for Guillain-Barré syndrome: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2003) 2.76
Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Ann Neurol (1990) 2.66
Monoclonal antibody that recognizes an outer membrane antigen common to the pathogenic Neisseria species but not to most nonpathogenic Neisseria species. Infect Immun (1984) 2.65
Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain (1995) 2.61
Epstein-Barr virus in AIDS-related primary central nervous system lymphoma. Lancet (1991) 2.60
Evaluation of several commercial biochemical and immunologic methods for rapid identification of gram-positive cocci directly from blood cultures. J Clin Microbiol (1988) 2.54
Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann Neurol (1992) 2.52
Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy. Neurology (1999) 2.52
HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy. Neurology (1999) 2.49
Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Ann Neurol (1998) 2.47
Clinical-neuropathologic correlation in HIV-associated dementia. Neurology (1993) 2.47
Investigating non-response bias in mail surveys. J Epidemiol Community Health (1981) 2.43
Myelin-associated glycoprotein is a myelin signal that modulates the caliber of myelinated axons. J Neurosci (1998) 2.43
Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease. Cell (1993) 2.40
Neurofilament gene expression: a major determinant of axonal caliber. Proc Natl Acad Sci U S A (1987) 2.36
Multifocal motor neuropathy: response to human immune globulin. Ann Neurol (1993) 2.32
Patterns of Guillain-Barre syndrome in children: results from a Mexican population. Neurology (2007) 2.32
Inappropriate testing for diarrheal diseases in the hospital. JAMA (1990) 2.31
Diffusion- and perfusion-weighted brain magnetic resonance imaging in patients with neurologic complications after cardiac surgery. Arch Neurol (2001) 2.30
Guillain-Barré syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases. Brain (1995) 2.29
Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann Neurol (1993) 2.23
Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry. Ann Neurol (1996) 2.22
Demented and nondemented patients with AIDS differ in brain-derived human immunodeficiency virus type 1 envelope sequences. J Virol (1994) 2.21
Adrenomyeloneuropathy: a probable variant of adrenoleukodystrophy. I. Clinical and endocrinologic aspects. Neurology (1977) 2.19
Evaluation of a rapid system for species identification of alpha-hemolytic streptococci. J Clin Microbiol (1982) 2.18
Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia. Neurology (2004) 2.18
Neuropsychological performance in HIV-1-infected homosexual men: The Multicenter AIDS Cohort Study (MACS) Neurology (1990) 2.17
Incidence of and risk factors for HIV-associated distal sensory polyneuropathy. Neurology (2002) 2.17
Campylobacter laridis causing bacteremia in an immunosuppressed patient. Ann Intern Med (1984) 2.14
Repeatability and validity of a modified activities of daily living (ADL) index in studies of chronic disability. Int Rehabil Med (1979) 2.14
A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside. Ann Neurol (1988) 2.12
Monoclonal antibodies against Neisseria gonorrhoeae: production of antibodies directed against a strain-specific cell surface antigen. Infect Immun (1981) 2.09
Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia. Ann Neurol (1993) 2.09
HIV neuropathy natural history cohort study: assessment measures and risk factors. Neurology (2006) 2.06
Beta-chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia. Ann Neurol (1998) 2.05
Inflammatory demyelinating peripheral neuropathies associated with human T-cell lymphotropic virus type III infection. Ann Neurol (1987) 2.05
Control of axonal caliber by neurofilament transport. J Cell Biol (1984) 2.03
Dynamics of geckos running vertically. J Exp Biol (2006) 2.00
Slow axonal transport of neurofilament proteins: impairment of beta,beta'-iminodipropionitrile administration. Science (1978) 2.00
Cellular autofluorescence--is it due to flavins? J Histochem Cytochem (1979) 1.99
Schwann cells express motor and sensory phenotypes that regulate axon regeneration. J Neurosci (2006) 1.97
Mice lacking complex gangliosides develop Wallerian degeneration and myelination defects. Proc Natl Acad Sci U S A (1999) 1.95
Cutaneous innervation in sensory neuropathies: evaluation by skin biopsy. Neurology (1995) 1.95
Predominantly sensory neuropathy in patients with AIDS and AIDS-related complex. Neurology (1988) 1.94
Epidermal nerve fiber density and sural nerve morphometry in peripheral neuropathies. Neurology (1999) 1.93
Ataxic sensory neuropathy and dorsal root ganglionitis associated with Sjögren's syndrome. Ann Neurol (1990) 1.92
Common and variable domains of the flagellin gene, flaA, in Campylobacter jejuni. Mol Microbiol (1991) 1.92
Temporal trends in the incidence of HIV-1-related neurologic diseases: Multicenter AIDS Cohort Study, 1985-1992. Neurology (1994) 1.88
Axotomy-induced axonal degeneration is mediated by calcium influx through ion-specific channels. J Neurosci (1995) 1.88
Western blot analysis of the human antibody response to Campylobacter jejuni cellular antigens during gastrointestinal infection. J Clin Microbiol (1985) 1.86
Pathology of the motor-sensory axonal Guillain-Barré syndrome. Ann Neurol (1996) 1.85
Remedial therapy after stroke: a randomised controlled trial. Br Med J (Clin Res Ed) (1981) 1.84
Cognitive changes 5 years after coronary artery bypass grafting: is there evidence of late decline? Arch Neurol (2001) 1.83
Characterization of Neisseria gonorrhoeae protein II phase variation by use of monoclonal antibodies. Infect Immun (1984) 1.83